These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 26838200)
1. Immunohistochemical Evaluation of Glucose Transporter Type 1 in Epithelial Dysplasia and Oral Squamous Cell Carcinoma. Pereira KM; Feitosa SG; Lima AT; Luna EC; Cavalcante RB; de Lima KC; Chaves FN; Costa FW Asian Pac J Cancer Prev; 2016; 17(1):147-51. PubMed ID: 26838200 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical Evaluation of GLUT-3 and GLUT-4 in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma. Feitosa SG; Viana KF; Luna ECM; Costa FWG; Cavalcante RB; Chaves FN; Chaves HV; Pereira KMA Asian Pac J Cancer Prev; 2018 Jul; 19(7):1779-1783. PubMed ID: 30049187 [TBL] [Abstract][Full Text] [Related]
3. Risk prediction for malignant conversion of oral epithelial dysplasia by hypoxia related protein expression. Zhang X; Han S; Han HY; Ryu MH; Kim KY; Choi EJ; Cha IH; Kim J Pathology; 2013 Aug; 45(5):478-83. PubMed ID: 23811806 [TBL] [Abstract][Full Text] [Related]
4. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma. Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of VEGF, BDNF, TRKB expression in oral epithelial dysplasia, oral verrucous carcinoma and oral squamous cell carcinoma and their role as prognostic indicator. Priyadharshini KI; Balakrishnan S; Saranyan R; Nirmal M; Murugesan A; Yoithappra Bhunath TPR J Cancer Res Ther; 2024 Jul; 20(5):1376-1383. PubMed ID: 39412903 [TBL] [Abstract][Full Text] [Related]
6. A correlation of immunohistochemical expression of Pandya JA; Boaz K; Natarajan S; Manaktala N; Nandita KP; Lewis AJ J Cancer Res Ther; 2018; 14(3):666-670. PubMed ID: 29893337 [TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity and immunoexpression of PTEN in oral epithelial dysplasia and squamous cell carcinoma. Chaves FN; Bezerra TMM; Moraes DC; Costa SFDS; Silva PGB; Alves APNN; Costa FWG; Bernardes VF; Pereira KMA Exp Mol Pathol; 2020 Feb; 112():104341. PubMed ID: 31730755 [TBL] [Abstract][Full Text] [Related]
9. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573 [TBL] [Abstract][Full Text] [Related]
10. PI3K-AKT-mTOR pathway proteins are differently expressed in oral carcinogenesis. Martins F; de Sousa SC; Dos Santos E; Woo SB; Gallottini M J Oral Pathol Med; 2016 Nov; 45(10):746-752. PubMed ID: 26991907 [TBL] [Abstract][Full Text] [Related]
11. Ribosomal protein S6 phosphorylation is associated with epithelial dysplasia and squamous cell carcinoma of the oral cavity. Chaisuparat R; Rojanawatsirivej S; Yodsanga S Pathol Oncol Res; 2013 Apr; 19(2):189-93. PubMed ID: 23015458 [TBL] [Abstract][Full Text] [Related]
13. Expression of CDK6 in Oral Squamous Cell Carcinomas. Andisheh-Tadbir A; Ashraf MJ; Jeiroodi N Asian Pac J Cancer Prev; 2018 Apr; 19(4):1013-1016. PubMed ID: 29693970 [TBL] [Abstract][Full Text] [Related]
14. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia? Chen YK; Hsue SS; Lin LM Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192 [TBL] [Abstract][Full Text] [Related]
15. Joint detection of claudin-1 and junctional adhesion molecule-A as a therapeutic target in oral epithelial dysplasia and oral squamous cell carcinoma. Upadhaya P; Barhoi D; Giri A; Bhattacharjee A; Giri S J Cell Biochem; 2019 Oct; 120(10):18117-18127. PubMed ID: 31161679 [TBL] [Abstract][Full Text] [Related]
16. Stathmin! An immunohistochemical analysis of the novel marker in Oral Squamous Cell Carcinoma and Oral Leukoplakia. Vadla P; Yeluri S; Deepthi G; Guttikonda VR; Taneeru S; Naramala S Asian Pac J Cancer Prev; 2020 Nov; 21(11):3317-3323. PubMed ID: 33247690 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma. Sutariya RV; Manjunatha BS J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339 [TBL] [Abstract][Full Text] [Related]
18. Expression of CLLD7 and CHC1L Proteins in Oral Epithelial Dysplasia in a Group of Thai Patients. Wiphakphongpakorn P; Juengsomjit R; Poomsawat S; Meesakul O; Bhattarai BP; Klongnoi B; Buajeeb W; Khovidhunkit SP Asian Pac J Cancer Prev; 2024 Apr; 25(4):1257-1264. PubMed ID: 38679985 [TBL] [Abstract][Full Text] [Related]
19. A comparative analysis of langerhans cell in oral epithelial dysplasia and oral squamous cell carcinoma using antibody CD-1a. Upadhyay J; Rao NN; Upadhyay RB J Cancer Res Ther; 2012; 8(4):591-7. PubMed ID: 23361280 [TBL] [Abstract][Full Text] [Related]
20. CD133 Role in Oral Carcinogenesis. Luna ECM; Bezerra TMM; Barros Silva PG; Cavalcante RB; Costa FWG; Alves APNN; Chaves FN; Pereira KMA Asian Pac J Cancer Prev; 2020 Sep; 21(9):2501-2506. PubMed ID: 32986345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]